These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 37732142)

  • 21. Calpain inhibition: a therapeutic strategy targeting multiple disease states.
    Carragher NO
    Curr Pharm Des; 2006; 12(5):615-38. PubMed ID: 16472152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulating cell migration: calpains make the cut.
    Franco SJ; Huttenlocher A
    J Cell Sci; 2005 Sep; 118(Pt 17):3829-38. PubMed ID: 16129881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calpain as a therapeutic target in traumatic brain injury.
    Saatman KE; Creed J; Raghupathi R
    Neurotherapeutics; 2010 Jan; 7(1):31-42. PubMed ID: 20129495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulators of calpain activity: inhibitors and activators as potential drugs.
    Dókus LE; Yousef M; Bánóczi Z
    Expert Opin Drug Discov; 2020 Apr; 15(4):471-486. PubMed ID: 32022614
    [No Abstract]   [Full Text] [Related]  

  • 25. Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?
    Baudry M
    Curr Neuropharmacol; 2019; 17(9):823-829. PubMed ID: 30819083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ca2+-regulated enzymes calpain and calcineurin in neurodegenerative processes and prospects for neuroprotective pharmacotherapy].
    Knaryan VH; Sarukhanyan FP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):32-40. PubMed ID: 37490663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of functionally diverse calpain system on immune cells.
    Chen Y; Su Z; Liu F
    Immunol Res; 2021 Feb; 69(1):8-17. PubMed ID: 33483937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of calpain in oncotic cell death.
    Liu X; Van Vleet T; Schnellmann RG
    Annu Rev Pharmacol Toxicol; 2004; 44():349-70. PubMed ID: 14744250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.
    Baudry M; Bi X
    Trends Neurosci; 2016 Apr; 39(4):235-245. PubMed ID: 26874794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic role of calpains in postischemic neurodegeneration.
    Bevers MB; Neumar RW
    J Cereb Blood Flow Metab; 2008 Apr; 28(4):655-73. PubMed ID: 18073773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder.
    Wu HY; Tomizawa K; Matsui H
    Acta Med Okayama; 2007 Jun; 61(3):123-37. PubMed ID: 17593948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.
    Rao MV; Mohan PS; Peterhoff CM; Yang DS; Schmidt SD; Stavrides PH; Campbell J; Chen Y; Jiang Y; Paskevich PA; Cataldo AM; Haroutunian V; Nixon RA
    J Neurosci; 2008 Nov; 28(47):12241-54. PubMed ID: 19020018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity.
    Menzies FM; Garcia-Arencibia M; Imarisio S; O'Sullivan NC; Ricketts T; Kent BA; Rao MV; Lam W; Green-Thompson ZW; Nixon RA; Saksida LM; Bussey TJ; O'Kane CJ; Rubinsztein DC
    Cell Death Differ; 2015 Mar; 22(3):433-44. PubMed ID: 25257175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conventional calpains and programmed cell death.
    Łopatniuk P; Witkowski JM
    Acta Biochim Pol; 2011; 58(3):287-96. PubMed ID: 21887410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of BDNF/TrkB signaling mediated by NMDAR/Ca
    Qiu LL; Pan W; Luo D; Zhang GF; Zhou ZQ; Sun XY; Yang JJ; Ji MH
    J Neuroinflammation; 2020 Jan; 17(1):23. PubMed ID: 31948437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calpain activity is negatively regulated by a KCTD7-Cullin-3 complex via non-degradative ubiquitination.
    Sharma J; Mulherkar S; Chen UI; Xiong Y; Bajaj L; Cho BK; Goo YA; Leung HE; Tolias KF; Sardiello M
    Cell Discov; 2023 Mar; 9(1):32. PubMed ID: 36964131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction.
    Nimmrich V; Szabo R; Nyakas C; Granic I; Reymann KG; Schröder UH; Gross G; Schoemaker H; Wicke K; Möller A; Luiten P
    J Pharmacol Exp Ther; 2008 Nov; 327(2):343-52. PubMed ID: 18701765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gel-based protease proteomics for identifying the novel calpain substrates in dopaminergic neuronal cell.
    Kim C; Yun N; Lee YM; Jeong JY; Baek JY; Song HY; Ju C; Youdim MB; Jin BK; Kim WK; Oh YJ
    J Biol Chem; 2013 Dec; 288(51):36717-32. PubMed ID: 24235151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of calpain cleavage sites in the G1 cyclin-dependent kinase inhibitor p19(INK4d).
    Joy J; Nalabothula N; Ghosh M; Popp O; Jochum M; Machleidt W; Gil-Parrado S; Holak TA
    Biol Chem; 2006 Mar; 387(3):329-35. PubMed ID: 16542156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calpains and delayed calcium deregulation in excitotoxicity.
    Araújo IM; Carreira BP; Carvalho CM; Carvalho AP
    Neurochem Res; 2010 Dec; 35(12):1966-9. PubMed ID: 21110090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.